Association of the Composition of the Bone Marrow Tumor Microenvironment in BCR::ABL1-Negative Myeloproliferative Neoplasms with IFN-γ Signaling and Driver Mutations

JAK2-mutated myeloproliferative neoplasms exhibit an intrinsic activation of interferon-γ signaling associated with changes in the bone marrow tumor microenvironment and patients’ outcome.